Kiran Mazumdar-Shaw: building Biocon around affordable biotechnology
Kiran Mazumdar-Shaw founded Biocon in 1978 and built it into an Indian biopharmaceutical company focused on biologics and biosimilars.
Kiran Mazumdar-Shaw founded Biocon in 1978 and serves as its Executive Chairperson. Her career is linked to the growth of India's biotechnology and biopharmaceutical industry, including biosimilars and more accessible medicines.
From a start-up to a biotechnology company
Mazumdar-Shaw founded Biocon in Bengaluru in 1978. The company began in industrial enzymes and later expanded into biopharmaceuticals. Its development reflects the long path from a small technical venture to a research, manufacturing and global-regulatory business.
Focus on biologics and access
Biocon and its subsidiaries have worked across insulin, biologics and biosimilars. These products require complex manufacturing and quality systems, so the business depends on process science, regulatory approvals and large-scale production.
Leadership beyond the company
Her public work has also included philanthropy and support for health and science initiatives. For current corporate titles and board responsibilities, the company's official leadership page is the primary reference.
Frequently asked questions
When was Biocon founded?
Kiran Mazumdar-Shaw founded Biocon in 1978.
What is her role at Biocon?
The company's leadership page lists her as Executive Chairperson.